Magnolioside

CAS : 20186-29-2

Ref. 3D-VAA18629

Informations sur le produit

• Nom: Magnolioside
• Synonymes: 2H-1-Benzopyran-2-one, 6-(b-D-glucopyranosyloxy)-7-methoxy-, 2H-1-Benzopyran-2-one, 6-(beta-D-glucopyranosyloxy)-7-methoxy-
• CAS: 20186-29-2

Description

Magnolioside is a bioactive compound that has been shown to have potent anti-inflammatory effects. It has been shown to inhibit the production of pro-inflammatory cytokines, such as tumor necrosis factor (TNF) and interleukin-1β (IL-1β), by inhibiting the activation of nuclear factor kappa B (NFκB). Magnolioside also inhibits the production of cyclooxygenase-2 (COX-2) and reduces the production of prostaglandins. This compound also has neuroprotective effects and was found to be effective against radiation-induced cognitive impairment in rats. Magnolioside is cytotoxic to cancer cells, including colorectal cancer cell lines, and may be a potential anticancer agent for colon cancer. The mechanism by which Magnolioside exerts its cytotoxic effect on cancer cells is not well understood; however, it may involve modulation of cellular signaling pathways or inhibition of

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 354.31 g/mol
• Formule: C₁₆H₁₈O₉
• Degré de pureté: Min. 95%